Drugs / Clostridium butyricum TO-A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT04688242 | Feb 2021 → Dec 2023 | — | Sixth Affiliated Hospital, Sun Yat-sen University | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT03613545 Comparator | Aug 2018 → Dec 2028 expected | irritable bowel syndrome | Guangzhou First People's Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clostridium butyricum TO-A | “Clostridium butyricum TO-A” NCT03613545 ↗ |